Our group’s overall goal is to design and deploy active biohybrid systems in the forms of nano- and microparticles, hydrogels, living cells, and their derivatives to study and regulate biointerfacial and biotransport processes relevant to human and environmental health for multiple applications, including drug delivery, diagnosis/bioimaging, 3D cell culture and therapies, and tissue repair and regeneration.

To achieve this goal, we focus on the synthesis, characterization, and processing of ABMs with desired structure, property, and functionality. We also study an emergent behavior of these ABMs for (1) biofilm removal, (2) biofabrication of muscle-neural interface, (3) cell regulation, and (4) biotransport in neural computing models.